Jerel Davis
SEC CIK 1745958 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Dir, 10% | 1.53M | $3.06M | — | 2 | 2021-06-29 | 2021-06-29 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Jerel Davis made no open-market trades at LENZ in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-07-01 | 2021-06-29 | LENZ | LENZ Therapeutics, Inc. | Jerel Davis | Dir, 10% | C - Cnv Deriv | — | +13.87M | 1.53M | New | — |
| DI | 2021-07-01 | 2021-06-29 | LENZ | LENZ Therapeutics, Inc. | Jerel Davis | Dir, 10% | P - Purchase | $17.00 | +180.0K | 1.71M | +12% | +$3.06M |
Purchase Sale Sale after option exercise All abbreviations